Skip to main content
SpringerLink
Log in
Book cover

Biological Aspects of Brain Tumors pp 63–72Cite as

A Molecular Basis for Multidrug-Resistance and Reversal of the Resistance

  • Chapter

Abstract

The development of multidrug-resistance (MDR) is a serious problem during treatment of various malignant tumors. Multidrug-resistant cells were isolated from human carcinoma cell lines and studied to elucidate the molecular basis for their multidrug resistance properties [1–4].

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Biedler JL, Riehm H (1970) Cellular resistance to actinomycin D in Chinese hamster cells in vitro: Cross-resistance, radioautographic, and cytogenetic studies. Cancer Res 30: 1174–1184

    PubMed  CAS  Google Scholar 

  2. Ling V, Thompson LH (1973) Reduced permeability in CHO cells as a mechanism of resistance to colchicine. J Cell Physiol 83: 103–116

    Article  Google Scholar 

  3. Beck WT, Mueller TJ, Tanzer LR (1979) Altered surface membrane glycoproteins in Vinca alkaloid-resistant human leukemic lymphoblasts. Cancer Res 39: 2070–2076

    PubMed  CAS  Google Scholar 

  4. Akiyama S, Fojo A, Hanover JA, Pastan I, Gottesman MM (1985) Isolation and genetic characterization of human KB cell lines resistant to multiple drugs. Somatic Cell Mol Genet 11: 117–126

    Article  CAS  Google Scholar 

  5. Juliano RL, Ling V (1976) A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 455: 152–162

    Article  PubMed  CAS  Google Scholar 

  6. Kartner, N, Evernden-Porelle D, Bradley G, Ling V (1985) Detection of P-glyco- protein in multidrug-resistant cell lines by monoclonal antibodies. Nature 316: 820–823

    Article  PubMed  CAS  Google Scholar 

  7. Kartner N, Riordan JR, Ling V (1983) Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. Science 221: 1285–1288

    Article  PubMed  CAS  Google Scholar 

  8. Shen DW, Cardarelli C, Hwang J, Cornwell MM, Richert N, Ishii S, Pastan I, Gottesman MM (1986) Multiple drug resistant human KB carcinoma cells in-dependently selected for high-level resistance to colchicine, Adriamycin, or vinblastine show changes in expression of specific proteins. J Biol Chem 261: 7762–7770

    PubMed  CAS  Google Scholar 

  9. Chen CJ, Chin JE, Ueda K, Clark DP, Pastan I, Gottesman MM, Roninson IB (1986) Internal duplication and homology with bacterial transport proteins in the mdrl ( P-glycoprotein) gene from multidrug-resistant human cells. Cell 47: 381–389

    Article  PubMed  CAS  Google Scholar 

  10. Gros P, Croop J, Housman D (1986) Mammalian multidrug resistance gene: Complete cDNA sequence indicates strong homology to bacterial transport protein. Cell 47: 371–380

    Article  PubMed  CAS  Google Scholar 

  11. Gerlach JH, Endicot A, Juranka R, Henderson G, Sarangi F, Deuchars KL, Ling V (1986) Homology between P-glycoprotein and a bacterial haemolysin transport protein suggests a model for multidrug resistance. Nature 324: 485–489

    Article  PubMed  CAS  Google Scholar 

  12. Cornwell MM, Safa AR, Felsted RL, Gottesman MM, Pastan I (1986) Membrane vesicles from multidrug-resistant human cancer cells contain a specific 150 to 170 kDa protein detected by photoaffinity labeling. Proc Natl Acad Sci USA 83: 3847–3850

    Article  PubMed  CAS  Google Scholar 

  13. Safa AR, Glover CJ, Meyers MB, Biedler JL, Felsted RL (1986) Vinblastine photoaffinity labeling of a high molecular weight surface membrane glycoprotein specific for multidrug-resistant cells. J Biol Chem 26: 6137–6140

    Google Scholar 

  14. Akiyama S, Cornwell MM, Kuwano M, Pastan I, Gottesman MM (1988) Most drugs that reverse multidrug resistance also inhibit photoaffinity labeling of P- glycoprotein by a vinblastine analog. Mol Pharmacol 33: 144–147

    PubMed  CAS  Google Scholar 

  15. Safa AR, Glover CJ, Sewell JL, Meyers MB, Biedler JL, Felsted RL (1987) Identification of the multidrug resistance-related membrane glycoprotein as an acceptor for calcium channel blockers. J Biol Chem 262: 7884–7888

    PubMed  CAS  Google Scholar 

  16. Safa AR (1988) Photoaffinity labeling of the multidrug-resistance related P- glycoprotein with photoactive analogs of verapamil. Proc Natl Acad Sci USA 85: 7187–7191

    Article  PubMed  CAS  Google Scholar 

  17. Akiyama S, Yoshimura A, Kikuchi H, Sumizawa, T, Kuwano M, Tahara Y (1989) Synthetic isoprenoid photoaffinity labeling of P-glycoprotein specific to multidrug- resistant cells. Mol Pharmacol 36: 730–735

    PubMed  CAS  Google Scholar 

  18. Cornwell MM, Tsuruo T, Gottesman MM, Pastan I (1987) ATP-binding properties of P-glycoprotein from multidrug-resistant KB cells. FASEB J 1: 51–54

    PubMed  CAS  Google Scholar 

  19. Gottesman MM, Pastan I (1988) The multidrug transporter, a double-edged sword. J Biol Chem 263: 12163 - 12166

    PubMed  CAS  Google Scholar 

  20. Kuwazuru Y, Yoshimura A, Hanada S, Ichikawa M, Saito T, Uozumi K, Utsuno- miya A, Arima T, Akiyama S (1990) Expression of the multidrug transporter, P-glycoprotein, in chronic myelogenous leukemia cells in blast crisis. Brit J Haematol 74: 24–29

    Article  CAS  Google Scholar 

  21. Kuwazuru Y, Yoshimura A, Hanada S, Makino T, Terada A, Utsunomiya A, Arima T, Akiyama S (1990) Expression of the multidrug transporter, P-glycoprotein, in acute leukemia cells and correlation to clinical drug resistance. Cancer 66: 868–873

    Article  PubMed  CAS  Google Scholar 

  22. Kuwazuru Y, Hanada S, Furukawa T, Yoshimura A, Sumizawa T, Utsunomiya A, Ishibashi K, Saito T, Arima T, Akiyama S (1990) Expression of P-glycoprotein in adult T cell leukemia cells. Blood 76: 2065–2071

    PubMed  CAS  Google Scholar 

  23. Mizoguchi T, Yamada K, Furukawa T, Hidaka K, Hisatsugu T, Shimazu H, Tsuruo T, Sumizawa T, Akiyama S (1990) Expression of the MDR1 gene in human gastric and colorectal carcinomas. J Natl Cancer Inst 82: 1679–1683

    Article  PubMed  CAS  Google Scholar 

  24. Kamiwatari M, Nagata Y, Kikuchi H, Yoshimura A, Sumizawa T, Shudo N, Sakoda R, Seto K, Akiyama S (1989) Correlation between reversing of multidrug resistance and inhibiting to [3H]azidopine photolabeling of P-glycoprotein by newly synthesized dihydropyridine analogues in a human cell line. Cancer Res 49: 3190–3195

    PubMed  CAS  Google Scholar 

  25. Shudo N, Mizoguchi T, Kiyosue T, Arita M, Yoshimura A, Seto K, Sakoda R, Akiyama S (1990) Two pyridine analogues with more effective ability to reverse

    Google Scholar 

  26. Cornwell MM, Safa AR, Felsted RL, Gottesman MM, Pastan I (1986) Membrane vesicles from multidrug resistant human cancer cells contain a specific 150 to 170 kDa protein detected by photoaffinity labeling. Proc Natl Acad Sci USA 83: 3847–3850

    Article  PubMed  CAS  Google Scholar 

  27. Safa AR, Glover CJ, Sewell JL, Meyers MB, Biedler JL, Felsted RL (1987) Identification of the multidrug resistance-related membrane glycoprotein as an acceptor for calcium channel blockers. J Biol Chem 262: 7884–7888

    PubMed  CAS  Google Scholar 

  28. Yoshimura A, Kuwazuru Y, Sumizawa T, Ichikawa M, Ikeda S, Uda T, Akiyama S (1989) Cytoplasmic orientation and two-domain structure of the multidrug transporter, P-glycoprotein, demonstrated with sequence-specific antibodies. J Biol Chem 264: 16282–16291

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cancer Chemotherapy, Institute of Cancer Research, Faculty of Medicine, Kagoshima University, Kagoshima, 890, Japan

    Tatsuhiko Furukawa

Authors
  1. Shin-Ichi Akiyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Akihiko Yoshimura
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Misako Ichikawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Tomoyuki Sumizawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tatsuhiko Furukawa
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Neurosurgery, Saga Medical School, Nabeshima, Saga, 849, Japan

    Kazuo Tabuchi M. D. (Professor and Chairman) (Professor and Chairman)

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer-Verlag Tokyo

About this chapter

Cite this chapter

Akiyama, SI., Yoshimura, A., Ichikawa, M., Sumizawa, T., Furukawa, T. (1991). A Molecular Basis for Multidrug-Resistance and Reversal of the Resistance. In: Tabuchi, K. (eds) Biological Aspects of Brain Tumors. Springer, Tokyo. https://doi.org/10.1007/978-4-431-68150-2_6

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-68150-2_6

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-68152-6

  • Online ISBN: 978-4-431-68150-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation